Inventor
KHARBANDA SURENDER
US18 patents
⚠️ This page may combine multiple inventors who share the name “KHARBANDA SURENDER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DANA FARBER CANCER INST INC
9 patentsUS11136410B2Oct 5, 2021
Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)
DANA FARBER CANCER INST INC2 citations72
US10059775B2Aug 28, 2018
Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)
DANA FARBER CANCER INST INC2 citations72
US9546201B2Jan 17, 2017
MUC-1 cytoplasmic domain peptides as inhibitors of cancer
DANA FARBER CANCER INST INC3 citations72
US12466895B2Nov 11, 2025
Antibodies against the MUC1-c/extracellular domain (MUC1-C/ECD)
DANA FARBER CANCER INST INC0 citations62
US10617773B2Apr 14, 2020
Antibodies against the MUC1-C/extracellular domain (MUC1-C/ECD)
DANA FARBER CANCER INST INC1 citations62
US9789156B2Oct 17, 2017
Combination anti-human epidermal growth factor receptor 2 (anti-HER2) cancer therapy using mucin 1 (MUC1) peptides and hemotherapeutics
DANA FARBER CANCER INST INC0 citations51
US9663562B2May 30, 2017
Compositions and methods for treating cancer
DANA FARBER CANCER INST INC0 citations51
US9572855B2Feb 21, 2017
Combination anti-estrogen receptor cancer therapy using MUC1 peptides and chemotherapeutics
DANA FARBER CANCER INST INC0 citations51
US9096687B2Aug 4, 2015
Inhibition of inflammation using antagonists of MUC1
DANA FARBER CANCER INST INC1 citations51
KUFE DONALD W
5 patentsUS8524669B2Sep 3, 2013
MUC-1 cytoplasmic domain peptides as inhibitors of cancer
KUFE DONALD W6 citations83
US8957185B2Feb 17, 2015
MUC-1 cytoplasmic domain peptides as inhibitors of cancer
KUFE DONALD W1 citations61
US8614186B2Dec 24, 2013
Inhibition of inflammation using antagonists of MUC1
KUFE DONALD W3 citations61
US8952054B2Feb 10, 2015
Small molecule inhibitors of MUC1 and methods of identifying the same
KUFE DONALD W1 citations51
US8685928B2Apr 1, 2014
Antagonists of MUC1
KUFE DONALD W1 citations51